Completed PHASE3 INTERVENTIONAL NCT00118820

Antibiotic Efficacy in Third Molar Surgery

Sponsor: Massachusetts General Hospital

Conditions Alveolar Osteitis Dry Socket Infection

Interventions IV Preoperative antibiotic or placebo

Updated 5 times since 2017 Last updated: Jul 14, 2010 Started: Mar 31, 2004 Primary completion: Jun 30, 2006 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00118820, this PHASE3 trial focuses on Alveolar Osteitis and Dry Socket and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 5 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
Oral and Maxillofacial Surgery Foundation, Rosemont ,Illinois

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States